Introduction {#Sec1}
============

Cortical lesions (CLs) in patients with multiple sclerosis (MS) are associated with physical disability \[[@CR1]\] and cognitive impairment \[[@CR2]\]; however, little is known about the formation and development of CLs due to their typically small size \[[@CR3]\] and the insufficient sensitivity and spatial resolution offered by conventional imaging modalities. Emerging techniques using ultra-high-field magnetic resonance imaging (MRI) can significantly improve the detection of CLs compared to 3 Tesla (T) scanners \[[@CR4]\], and can advance our understanding of how these lesions develop or resolve over time \[[@CR5]\].

Techniques including phase-sensitive inversion recovery (PSIR) \[[@CR6]\] and double inversion recovery (DIR) \[[@CR7]\] can identify CLs and track their structural development. However, it is also desirable to understand changes in physiology that may precede or dictate these overt structural changes. To date, the haemodynamic changes within CLs have been characterised using dynamic susceptibility contrast (DSC) MRI, revealing that local haemodynamics change with the status of the lesion: chronic CLs in grey matter exhibit reduced perfusion and cerebral blood volume \[[@CR8]--[@CR10]\], whereas in acute lesions elevated cerebral blood volume has been reported \[[@CR8]\]. Reports of changes in perfusion prior to lesion formation and contrast enhancement \[[@CR11]\] suggest that studies of local haemodynamics may predict such tissue damage, identifying a critical window for intervention.

To characterise rapid changes during periods of disease activity and CL development, patients must be scanned repeatedly and frequently. DSC MRI, although the clinical gold-standard for assessing haemodynamic changes, is not well suited to such longitudinal studies. Concerns over dose-dependent deposition of gadolinium-based contrast agents in the brain caution against frequent repeated exposure \[[@CR12]--[@CR15]\].

Arterial spin labelling (ASL) MRI provides an alternative method for quantifying local tissue perfusion that requires no injection of exogenous contrast. ASL has been successfully used to measure perfusion deficits in cortical grey matter in early stages of MS compared to healthy controls, demonstrating its clinical sensitivity \[[@CR16]\]. CL perfusion has been examined using Pseudo-Continuous ASL at 3T and DSC data collected to validate the results: there was poor agreement in perfusion quantification between the methods, highlighting the challenges in making robust ASL perfusion measurements in small CLs compared to larger regions, especially at coarser spatial resolution. The inherently low contrast-to-noise ratio of ASL techniques is substantially improved when scanning at ultra-high-field (here defined to be 7T) \[[@CR17]\], allowing data to be collected at higher spatial resolution. However, there are numerous challenges when performing ASL at 7T that require optimisation of the imaging protocol \[[@CR18]\]. In this study, we assess the feasibility of using an optimised, ultra-high-field, high-spatial resolution, low-distortion ASL acquisition \[[@CR19]\] to quantify perfusion in chronic CLs, demonstrating proof of concept that this technique is suitable for characterising local haemodynamic pathology in MS.

Materials and methods {#Sec2}
=====================

This cross-sectional prospective study was approved by the local research ethics authority. Twelve patients with MS were recruited after giving informed consent. All patients were selected based on having known pre-existing chronic CLs from scans of two prior studies \[[@CR6], [@CR20]\]. One of these studies developed the PSIR technique for improved CL detection \[[@CR6]\] and the second examined the 'central vein sign' in white matter lesions \[[@CR20]\]; neither of these earlier studies acquired ASL data or quantified perfusion. Both studies completed prior to the end of December 2014. Access to these earlier scans followed ethical guidelines to which consent was given. All scanning for this study took place between September and December 2015, at least 8 months after identification of CLs. As such, all CLs in this study are considered chronic.

The 12 recruited patients included seven relapsing-remitting and five progressive (four primary progressive and one secondary progressive) MS patients (eight male, four female; mean age 50 years (range 35--64); median Expanded Disability Status Scale 4.5 (range 2.0--6.0)).

Magnetic resonance acquisition {#Sec3}
------------------------------

MRI was performed on a 7T Philips Achieva scanner (Philips Medical Systems, Best, The Netherlands) using a 32-channel receive coil. Details of acquisition parameters are provided in Table [1](#Tab1){ref-type="table"}. To identify CLs, a whole-head PSIR scan was performed using a tailored adiabatic inversion pulse to ensure efficient inversion in areas of radio frequency (RF) inhomogeneities found at ultra-high field \[[@CR21]\]. The timings of the turbo field echo (TFE) readouts were optimised to suppress the signal from voxels containing equal amounts of grey and white matter, thus producing a clear observable boundary between them \[[@CR6]\]. The PSIR images were acquired at high spatial resolution (0.6 mm isotropic) to minimise partial volume effects in small CLs, allowing accurate boundary detection.Table 1Scan acquisition parameters. Acquisition parameters for the Phase Sensitive Inversion Recovery (PSIR) 3D turbo field echo (TFE) scan, and the single and multi-phase arterial spin labelling (ASL) scans with a balanced steady-state free precession (bSSFP) read-outParameterPSIRSingle-phase ASLMulti-phase ASLReadout3D-TFEbSSFPbSSFPField of view (AP, RL, FH)200 × 181 × 120 mm^3^192 × 192 × 3 mm^3^192 × 192 × 3 mm^3^Voxel size (AP, RL, FH)0.6 × 0.6 × 0.6 mm^3^1.2 × 1.2 × 3.0 mm^3^1.2 × 1.2 × 3.0 mm^3^Echo time (TE)6 ms1.9 ms1.9 msRepetition time (TR)13 ms3.8 ms3.8 msFlip angle8°50°35°SENSE (AP, RL, FH)2, 1, 21, 2.5, 11, 2.5, 1Post-labelling delay (PLD)-1,400 and 1,800 ms200, 550, 900, 1,250, 1,600, 1,960, 2,300, 2,650 msAverages15040Scan duration (mm:ss)12:555:06 per PLD6:40 all PLDs

ASL data were acquired using a flow-sensitive alternating inversion recovery (FAIR) ASL scheme with in-plane pre-saturation using a WET (Water suppression Enhanced through T1 effects) scheme and a sinc post-saturation pulse. A balanced steady-state free precession (bSSFP) readout was used to achieve high spatial resolution (1.2 × 1.2 × 3.0 mm^3^) with minimal distortions, essential for accurate co-registration of small CLs. A single axial imaging slice was positioned to transect one or more CLs identified from the PSIR acquisition. Single-phase ASL data were collected at post-labelling delay (PLD) of 1,400 and 1,800 ms to determine tissue perfusion (50 label-control pairs were acquired at each PLD, bSSFP readout collected using α/2 pulse at a time TR/2 before a train of RF pulses with α of 50^o^ to reach a steady state). In addition, multi-phase ASL data were acquired using a Look-Locker bSSFP readout (with flip angle α of 35°) comprising eight PLDs of 200, 550, 900, 1,250, 1,600, 1,960, 2,300 and 2,650 ms (40 label-control pairs, to estimate arterial transit time and locate intravascular signal contributions). An M~0~ image was acquired for both single- and multi-phase bSSFP acquisitions to allow absolute perfusion quantification.

Cortical lesion identification {#Sec4}
------------------------------

CLs were identified from the PSIR modulus image during the scanning session by a trained rater (YF) in order to position the ASL slice appropriately. CLs were selected as any hypointense demarcated lesions within the cortical ribbon, as described by Mougin et al \[[@CR6]\]. Masks were drawn around the CLs using MIPAV (Medical Imaging Processing Analysis and Visualisation, CIT, NIH, Bethesda, MD, USA).

Image co-registration {#Sec5}
---------------------

The ASL and PSIR sequences were acquired back-to-back, to minimise misalignments between these data acquisitions. However, in three patients there was significant movement between the ASL and PSIR scans. In order to accurately locate the CLs in ASL data-space, the PSIR data were co-registered to the ASL data. Due to the limited coverage of the ASL scan, automated co-registration techniques were not appropriate. Instead, the PSIR slices corresponding to the ASL slice were identified and corrective rotations were applied manually as needed using FSL FLIRT \[[@CR22]\]. The CL masks were then co-registered to the ASL data by applying these transformations.

ASL pre-processing {#Sec6}
------------------

The ASL data were brain extracted and motion corrected using 2D in-plane co-registration using FSL MCFLIRT \[[@CR23]\], and any label-control pairs that contained \> 1.2 mm translational movement (the in-plane resolution of the ASL voxels) were discarded. The label images were subtracted from the corresponding control images, and these difference images were averaged for each PLD using a Huber M-estimator to remove outlier signals and generate robust perfusion-weighted images \[[@CR24]\].

Perfusion quantification {#Sec7}
------------------------

The base M~0~ images were co-registered to the average ASL label image using FSL FLIRT. A T~1~ map was obtained by fitting the label images from the multi-phase ASL data to a Look-Locker saturation recovery curve:$$\documentclass[12pt]{minimal}
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The multi-phase ASL data were fit to the model described by Francis et al \[[@CR25]\] to produce a transit time map. This method also fits for perfusion; however, the SNR of the multi-phase ASL data is considerably lower than that of the single-phase ASL data \[[@CR26]\]. Thus, this transit time map, the T~1~ map, and the fitted value for the T~1~ of arterial blood were used with the averaged single-phase data in a model fit, as described by Gardener et al \[[@CR17]\], to quantify perfusion in ml/100 g tissue/min. To optimise this fit, the starting parameters were chosen by comparing the voxel-by-voxel ASL signal to a lookup table of modelled ASL signals. Parameters producing the best estimate (assessed using the sum of square differences) were used to initialise a Nelder-Mead simplex direct search implemented in MATLAB (The MathWorks, Inc., Natick, MA, USA).

CL perfusion was calculated by averaging the voxel-wise perfusion values inside the CL mask. A mask of local normal appearing grey matter (NAGM~local~) was created by dilating the CL mask to a radius of 12 mm, then restricting this to a grey matter mask obtained from segmenting the PSIR image using FSL FAST. The mean perfusion value inside this region, with the CL removed, was defined as NAGM~local~ perfusion. Finally, the average perfusion in total cortical normal appearing grey matter (NAGM~cortical~) was also computed.

Lesion eligibility {#Sec8}
------------------

Any CL with a volume of less than three ASL voxels (12.96 mm^3^) was discarded. As vascular crushing could not be applied in this bSSFP ASL acquisition, fitted perfusion values were influenced by both perfusion and intravascular blood flow contamination in the voxel. A histogram of NAGM~cortical~ perfusion values was created and fitted to a mixture model of Gaussians (allowing for multiple undetermined perfusion and inflow signal sources); any voxel containing a 'perfusion' peak value of five times greater than the NAGM~cortical~ perfusion peak was assumed to be dominated by vascular inflow, and this was used to create a vascular inflow mask. CLs overlapping with this mask were discarded.

Statistical comparison of CL and NAGM perfusion {#Sec9}
-----------------------------------------------

Paired two-sample t-tests were used to determine differences in perfusion (significance threshold *p* \< 0.05). Statistical analyses were performed using Minitab 17 Statistical Software (2010) (State College, PA, USA: Minitab, Inc. ([www.minitab.com](http://www.minitab.com))).

Results {#Sec10}
=======

Data from two participants were discarded due to head movement that moved CLs out of the ASL imaging volume. All remaining acquisitions were of sufficient quality to extract perfusion maps.

Cortical lesion identification {#Sec11}
------------------------------

In total, 40 CLs were identified in the PSIR scans that overlapped with the ASL slice acquisition. After applying the eligibility criteria, 27 of the 40 lesions remained for analysis (67.5%); four contained vascular contamination (10%), eight were below the volume threshold (20%) and one failed both tests (2.5%) (Table [2](#Tab2){ref-type="table"}). Examples of a PSIR image, perfusion-weighted ASL image, and CL, NAGM~local~ and NAGM~cortical~ masks are presented in Fig. [1a-c](#Fig1){ref-type="fig"}.Table 2Overview of identified cortical lesions (CLs)PatientCLsVolume (mm^3^)1427.86†, 21.60†, 8.42\*, 16.632513.18†, 15.12, 47.09, 14.043117.504344.50, 17.50, 19.445317.71, 30.02, 26.356629.38, 8.64\*, 17.93, 15.55, 6.48\*, 21.177422.03, 14.90, 25.49, 16.428515.98, 15.34, 7.13\*, 19.44, 15.98†9712.96, 7.56\*, 8.86\*, 8.86\*, 8.42\*, 14.26, 25.4910212.53\*, 18.36CLs (\*) with a cortical volume less than 12.96 mm^3^ were discounted from analysis, along with those CLs (†) that had large vessel contaminationFig. 1**a** Axial phase sensitive inversion recovery (PSIR) slice containing a cortical lesion (CL) indicated by the arrow. **b** Arterial spin labelling (ASL) perfusion map (ml/100 g/min) of slice shown in **a**. **c** Binary mask of the cortical lesion, local and cortical normal-appearing grey matter (NAGM~local~ and NAGM~cortical~). **d** Violin plot of perfusion within CLs, NAGM~local~ and NAGM~cortical~ with the mean indicated (black line)

Perfusion in CLs {#Sec12}
----------------

The mean perfusion was 40 ± 24 ml/100 g/min in CLs, 53 ± 12 ml/100 g/min in NAGM~local~, and 53 ± 8 ml/100 g/min in NAGM~cortical~ (Fig. [1d](#Fig1){ref-type="fig"}). When comparing perfusion inside a given lesion to the associated NAGM~local~, CL perfusion was significantly lower, by 23 ± 9% (mean ± standard error, *p* = 0.013), and significantly lower than NAGM~cortical~ perfusion, by 25 ± 9% (mean ± standard error, *p* = 0.006).

Discussion {#Sec13}
==========

To our knowledge, this is the first study measuring CL perfusion in MS using ASL at 7T. The majority of CLs showed hypoperfusion compared to NAGM, in line with the previous study by Peruzzo et al using DSC MRI at 1.5T \[[@CR9]\], demonstrating that this optimised ultra-high-field ASL-MRI technique is sensitive to the expected pathological hypoperfusion.

This was an exploratory study aimed at using ASL with a bSSFP acquisition scheme to collect high spatial resolution data and minimal distortions, following on from its development in healthy subjects \[[@CR19]\]. However, this restricted the acquisition to single-slice coverage, limiting our ability to robustly compare widespread cortical perfusion differences in patients compared to controls, and the clinical applicability of our technique. We are currently examining the reproducibility of 7T FAIR ASL with increased brain coverage using an alternative 3D-EPI acquisition scheme, for the comparison of perfusion measures in MS patients with controls. Using this imaging protocol in a test-retest study, we have recently demonstrated that 7T FAIR ASL cortical perfusion values are similarly repeatable in both MS patients and matched control subjects \[[@CR27]\]. Based on this empirical evidence, we do not expect FAIR ASL data quality to be systematically impaired in studies of MS cohorts. In order to assess the repeatability of highly focal perfusion values (e.g. the spatial scale of CLs) in different control and patient cohorts, further technical development is needed to simultaneously achieve high-resolution data with whole-brain coverage by combining the bSSFP acquisition with simultaneous multislice (SMS) methods.

The ASL PLDs used here were optimised for quantifying perfusion in cortical grey matter, and both PLDs and spatial resolution would need to be adjusted to achieve sufficient contrast-to-noise ratio for robust quantification of white matter perfusion, which is significantly lower than NAGM and has been shown to be of the order of 16 ml/100 g/min \[[@CR28]\]. Further generalisability of our observations is limited by the small sample size and heterogeneous disease course within our cohort. We plan to apply this new imaging protocol to study CL perfusion across the distinct MS subtypes to better understand variations in lesion development in this diverse patient group. Finally, previous work has reported poor agreement between ASL and DSC perfusion estimates in CLs at 3T \[[@CR29]\], and we are now seeking to validate our perfusion results derived from ASL in MS patients with results obtained using DSC-MRI, the clinical gold-standard technique \[[@CR27]\].

Unlike DSC, ASL requires no exogenous contrast agent, making it an appropriate tool to study dynamic perfusion changes in MS. ASL-MRI may facilitate the study of CL formation and development, to test new therapeutic strategies and better understand the heterogeneous disease course in MS.
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